Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

433 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292).
Kemeny MM, Zhao F, Forastiere AA, Catalano P, Hamilton SR, Miedema BW, Dawson NA, Weiner LM, Smith BD, Mason BA, Graziano SL, Gilman PB, Venook AP, Pinto HA, Whitehead RP, O'Dwyer PJ, Benson AB. Kemeny MM, et al. Among authors: benson ab. Ann Surg Oncol. 2023 Feb;30(2):1099-1109. doi: 10.1245/s10434-022-12705-8. Epub 2022 Oct 28. Ann Surg Oncol. 2023. PMID: 36305992 Free PMC article. Clinical Trial.
Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293.
Einzig AI, Neuberg D, Remick SC, Karp DD, O'Dwyer PJ, Stewart JA, Benson AB 3rd. Einzig AI, et al. Among authors: benson ab 3rd. Med Oncol. 1996 Jun;13(2):87-93. doi: 10.1007/BF02993858. Med Oncol. 1996. PMID: 9013471 Clinical Trial.
High dose chemoradiotherapy followed by esophagectomy for adenocarcinoma of the esophagus and gastroesophageal junction: results of a phase II study of the Eastern Cooperative Oncology Group.
Keller SM, Ryan LM, Coia LR, Dang P, Vaught DJ, Diggs C, Weiner LM, Benson AB. Keller SM, et al. Among authors: benson ab. Cancer. 1998 Nov 1;83(9):1908-16. doi: 10.1002/(sici)1097-0142(19981101)83:9<1908::aid-cncr5>3.0.co;2-6. Cancer. 1998. PMID: 9806648 Clinical Trial.
Eastern Cooperative Oncology Group Phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicity.
Talamonti MS, Catalano PJ, Vaughn DJ, Whittington R, Beauchamp RD, Berlin J, Benson AB 3rd. Talamonti MS, et al. Among authors: benson ab 3rd. J Clin Oncol. 2000 Oct 1;18(19):3384-9. doi: 10.1200/JCO.2000.18.19.3384. J Clin Oncol. 2000. PMID: 11013279 Clinical Trial.
NCCN Practice Guidelines for Colorectal Cancer.
Benson AB 3rd, Choti MA, Cohen AM, Doroshow JH, Fuchs C, Kiel K, Martin EW Jr, McGinn C, Petrelli NJ, Posey JA, Skibber JM, Venook A, Yeatman TJ; National Comprehensive Cancer Network. Benson AB 3rd, et al. Oncology (Williston Park). 2000 Nov;14(11A):203-12. Oncology (Williston Park). 2000. PMID: 11195411
Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B Study.
O'Dwyer PJ, Manola J, Valone FH, Ryan LM, Hines JD, Wadler S, Haller DG, Arbuck SG, Weiner LM, Mayer RJ, Benson AB 3rd. O'Dwyer PJ, et al. Among authors: benson ab 3rd. J Clin Oncol. 2001 May 1;19(9):2413-21. doi: 10.1200/JCO.2001.19.9.2413. J Clin Oncol. 2001. PMID: 11331320 Clinical Trial.
Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup study.
Kemeny MM, Adak S, Gray B, Macdonald JS, Smith T, Lipsitz S, Sigurdson ER, O'Dwyer PJ, Benson AB 3rd. Kemeny MM, et al. Among authors: benson ab 3rd. J Clin Oncol. 2002 Mar 15;20(6):1499-505. doi: 10.1200/JCO.2002.20.6.1499. J Clin Oncol. 2002. PMID: 11896097 Clinical Trial.
Randomized phase II trial of either fluorouracil, parenteral hydroxyurea, interferon-alpha-2a, and filgrastim or doxorubicin/docetaxel in patients with advanced gastric cancer with quality-of-life assessment: eastern cooperative oncology group study E6296.
Wadler S, Brain C, Catalano P, Einzig AI, Cella D, Benson AB 3rd. Wadler S, et al. Among authors: benson ab 3rd. Cancer J. 2002 May-Jun;8(3):282-6. doi: 10.1097/00130404-200205000-00013. Cancer J. 2002. PMID: 12074329 Clinical Trial.
433 results